Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Sep 18;10(9):1951. doi: 10.3390/plants10091951

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Mean ± SE percentage glucosinolate content related to control plants in kale genotypes high in glucobrassicin (HGBS), low in glucobrassicin (LGBS), high in sinigrin (HSIN), and low in sinigrin (LSIN). Data shown are from plants three days after application of phytohormones. The glucosinolates shown are total aliphatic (AL), total indolic (IN), and total glucosinolates (TO) for the treatments with jasmonic acid (JA), JA with larvae (JAL), and control with larvae (CL) (A) and after treatment with salicylic acid (SA), and SA with larvae (SAL) (B). Additionally, neoglucobrassicin is also shown for the treatments JA, JAL, CL, SA, and SAL (C). Post hoc tests with a significance level of p ≤ 0.05 were run to compare differences among genotypes within subgroups of treatment and glucosinolate content. Significant differences are shown with different lowercase letters.

Mean ± SE percentage glucosinolate content related to control plants in kale genotypes high in glucobrassicin (HGBS), low in glucobrassicin (LGBS), high in sinigrin (HSIN), and low in sinigrin (LSIN). Data shown are from plants three days after application of phytohormones. The glucosinolates shown are total aliphatic (AL), total indolic (IN), and total glucosinolates (TO) for the treatments with jasmonic acid (JA), JA with larvae (JAL), and control with larvae (CL) (A) and after treatment with salicylic acid (SA), and SA with larvae (SAL) (B). Additionally, neoglucobrassicin is also shown for the treatments JA, JAL, CL, SA, and SAL (C). Post hoc tests with a significance level of p ≤ 0.05 were run to compare differences among genotypes within subgroups of treatment and glucosinolate content. Significant differences are shown with different lowercase letters.